Kawarada Y, Isaji S, Taoka H, Tabata M, Das B C, Yokoi H
First Department of Surgery, Mie University School of Medicine, Tsu, Mie, Japan.
J Gastrointest Surg. 1999 Jul-Aug;3(4):369-73. doi: 10.1016/s1091-255x(99)80052-3.
Recently we have been performing S4a + S5 with total resection of the caudate lobe (S1) by using a dome-like dissection along the root of the middle hepatic vein at the pinnacle, which we refer to as the Taj Mahal liver parenchymal resection, for carcinoma of the biliary tract. This procedure offers the following advantages: (1) It allows total resection of the caudate lobe, including the paracaval portion (S9), and (2) because the cut surface of the liver is large, it allows intrahepatic jejunostomy to be performed more easily with a good field of view. The indications for this procedure include hilar bile duct carcinoma, gallbladder carcinoma, and choledochal cyst (type IVA). Because of the high rate of hilar liver parenchyma and caudate lobe invasion associated with hilar bile duct carcinoma, the liver must be resected. The Taj Mahal procedure is indicated in cases where extended liver resection is impossible. The dissection limits of this procedure are, on the left side, the B2+3 bifurcation at the right margin of the umbilical portion of the portal vein and, on the right side, the B8 of the anterior branch and the B6+7 bifurcation of the right posterior branch. This procedure could also be described as a reduced form of extended right hepatectomy and extended left hepatectomy. For gallbladder carcinoma, this procedure is indicated to ensure an adequate surgical margin and eradicate transvenous liver metastasis, particularly in cases of pT2 lesions. Hilar and caudate lobe invasion also occurs in liver bed-type gallbladder carcinoma, and bile duct resection and caudate lobe resection are required for the surgery to be curative. We performed this procedure in four cases of hilar bile duct carcinoma, five cases of gallbladder carcinoma, and one case each of choledochal cyst (type IVA) with carcinoma of the bile duct and gallbladder adenomyomatosis. Curative resection was possible in all except the patient with adenomyomatosis, and all of the patients are alive and recurrence free 10 to 37 months postoperatively. This procedure, in addition to preserving liver function, provides a wide field of view and facilitates reconstruction of multiple intrahepatic bile ducts. Thus it can be said to be a curative operation not only in patients considered high risk but also in those whose hilar bile duct carcinoma is limited to the bifurcation area (Bismuth type IIIa and IIIb) and in gallbladder carcinoma up to pT2 with slight extension on the hepatic side.
最近,我们一直在对胆道癌患者采用一种类似泰姬陵肝脏实质切除术的方法,即沿肝中静脉根部在肝尖处进行穹顶状解剖,以实现尾状叶(S1)的全切除并联合S4a+S5切除。该手术具有以下优点:(1)可实现尾状叶包括腔静脉旁部分(S9)的全切除;(2)由于肝脏切面大,便于在视野良好的情况下更轻松地进行肝内空肠吻合术。该手术的适应证包括肝门部胆管癌、胆囊癌和胆总管囊肿(IVA型)。鉴于肝门部胆管癌常伴有肝门部肝实质和尾状叶侵犯,必须进行肝脏切除。泰姬陵手术适用于无法进行扩大肝切除的病例。该手术的解剖界限为:左侧至门静脉脐部右侧缘的B2+3分支,右侧至肝右前叶的B8分支和右后叶的B6+7分支。该手术也可被视为扩大右肝切除和扩大左肝切除的简化形式。对于胆囊癌,该手术适用于确保足够的手术切缘并根除经静脉肝转移,尤其是对于pT2期病变。肝床型胆囊癌也会侵犯肝门和尾状叶,为实现根治性手术,需要进行胆管切除和尾状叶切除。我们对4例肝门部胆管癌、5例胆囊癌以及1例合并胆管癌的胆总管囊肿(IVA型)和胆囊腺肌增生症患者实施了该手术。除腺肌增生症患者外,所有患者均实现了根治性切除,所有患者术后存活,且在术后10至37个月内无复发。该手术除了保留肝功能外,还提供了广阔的视野,便于多条肝内胆管的重建。因此,可以说该手术不仅对高危患者是一种根治性手术方法,对于肝门部胆管癌局限于分叉区域(Bismuth IIIa型和IIIb型)以及肝侧有轻微侵犯的pT2期胆囊癌患者也是如此。